Description
Synthetic Biologics (formerly Adeona Corp.) is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases.
Team Members
Jeffrey Riley
CEO, President, and Director
John Monahan
Executive VP, Research & Development
Michael Kaleko
Senior VP, Research & Development
Joseph Silman
Senior VP, Clinical & Regulatory Affairs
Maureen Early,
VP, Commercial